Pilot study of sex differences in chemokine/cytokine markers of atherosclerosis in humans

Gender Medicine

Volumn 5, Issue 1, 2008, Pages 44-52

  Leung, Joseph ^a   Jayachandran, Muthuvel ^a   Kendall Thomas, June ^a   Behrenbeck, Thomas ^b   Araoz, Philip ^b   Miller, Virginia M ^a  

^a MAYO GRADUATE SCHOOL   (United States)

^b Mayo Clinic   (United States)

Author keywords

biomarkers; CCL5; PDGF; platelet derived growth factor; RANTES

Indexed keywords

ACETYLSALICYLIC ACID; ANTILIPEMIC AGENT; C REACTIVE PROTEIN; CHOLESTEROL; LIPID; ORAL CONTRACEPTIVE AGENT; PLATELET DERIVED GROWTH FACTOR BB; RANTES;

ADULT; ARTERY CALCIFICATION; ARTICLE; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; CORONARY ARTERY ATHEROSCLEROSIS; CYTOKINE RELEASE; DISEASE MARKER; DOT HYBRIDIZATION; FEMALE; HORMONE SUBSTITUTION; HUMAN; HYPERLIPIDEMIA; LIPID BLOOD LEVEL; MALE; MENOPAUSAL SYNDROME; PILOT STUDY; PREMENOPAUSE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; RISK FACTOR; SEX DIFFERENCE; SEX RATIO; UNITED STATES;

ATHEROSCLEROSIS; BLOOD PLATELETS; C-REACTIVE PROTEIN; CHEMOKINES; CHOLESTEROL; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; CYTOKINES; FEMALE; HUMANS; LIPIDS; MALE; MIDDLE AGED; PILOT PROJECTS; RISK FACTORS; SEX CHARACTERISTICS; SEX FACTORS;

EID: 41949097070     PISSN: 15508579     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1550-8579(08)80007-1     Document Type: Article

References (36)

1. Hayes I., Jordan N., Towers S., et al. Human vascular smooth muscle cells express receptors for CC chemokines. Arterioscler Thromb Vasc Biol 18 (1998) 397-403
2. Wick G., Schett G., Amberger A., et al. Is atherosclerosis an immunologically mediated disease?. Immunol Today 16 (1995) 27-33
3. Haraoka S., Shimokama T., and Watanabe T. Participation of Tlymphocytes in atherogenesis: Sequential and quantitative observation of aortic lesions of rats with dietinduced hypercholesterolaemia using en face double immunostaining. Virchows Arch 426 (1995) 307-315
4. Watanabe T., Shimokama T., Haraoka S., and Kishikawa H. T lymphocytes in atherosclerotic lesions. Ann N Y Acad Sci. 748 (1995) 40-55 discussion 55-56
5. Ross R. Glomset JA. The pathogenesis of atherosclerosis (second of two parts). N Engl J Med 295 (1976) 420-425
6. Pawlak K., and Pawlak D. Mysliwiec M. Circulating betachemokines and matrix metalloproteinase-9/tissue inhibitor of metalloproteinase-1 system in hemodialyzed patients - role of oxidative stress. Cytokine 31 (2005) 18-24
7. Libby P. Inflammation in atherosclerosis. Nature 420 (2002) 868-874
8. Sheikine Y. Hansson GK. Chemokines and atherosclerosis. Ann Med 36 (2004) 98-118
9. Mause S., von Hundelshausen P., Zernecke A., et al. Platelet microparticles: A transcellular delivery system for RANTES promoting monocyte recruitment on endothelium. Arterioscler Thromb Vasc Biol 25 (2005) 1512-1518
10. Eriksson E. Mechanisms of leukocyte recruitment to atherosclerotic lesions: Future prospects. Curr Opin Lipidol. 15 (2004) 553-558
11. Kher N. Marsh JD. Pathobiology of atherosclerosis- a brief review. Semin Thromb Hemost 30 (2004) 665-672
12. Schall T., and Bacon K. Chemokines, leukocyte trafficking, and inflammation. Curr Opin Immunol 6 (1994) 865-873
13. Schall T. Biology of the RANTES/SIS cytokine family. Cytokine 3 (1991) 165-183
14. Furie M. Randolph GJ. Chemokines and tissue injury. Am J Pathol 146 (1995) 1287-1301
15. Strieter R., Koch A., Antony V., et al. The immunopathology of chemotactic cytokines: The role of interleukin-8 and monocyte chemoattractant protein-1. J Lab Clin Med 123 (1994) 183-197
16. Kobusiak-Prokopowicz M., Orzeszko J., Mazur G., et al. Kinetics of chemokines in acute myocardial infarction. Kardiol Pol 62 (2005) 301-314
17. Ferroni P., Basili S., and Davi G. Platelet activation, inflammatory mediators and hypercholesterolemia. Curr Vasc Pharmacol Sin 1 (2003) 157-169
18. Sun W., Wang G., Zhang Z., et al. Chemokine RANTES is upregulated in monocytes from patients with hyperhomocysteinemia. Acta Pharmacol Sin 26 (2005) 1317-1321
19. Ridker P. C-reactive protein, inflammation, and cardiovascular disease. Clinical update. Tex Heart Inst J 32 (2005) 384-386
20. Miller V., and Redfield M. McConnell JP. Use of BNP and CRP as biomarkers in assessing cardiovascular disease: Diagnosis versus risk. Curr Vasc Pharmacol 5 (2007) 15-25
21. American Heart Association. Heart Disease and Stroke Statistics-2003 Update (2002), American Heart Association, Dallas, Tex
22. for the WISE Investigators. Shaw L., Bairey Merz C., Pepine C., et al. Insights from the NHLBI-sponsored Women′s Ischemia Syndrome Evaluation (WISE) Study: Part I: Gender differences in traditional and novel risk factors, symptom evaluation, and gender-optimized diagnostic strategies. J Am Coll Cardiol 47 (2006) S4-S20
23. Agatston A., Janowitz W., Hildner F., et al. Quantification of coronary artery calcium using ultrafast computed tomography. J Am Coll Cardiol 15 (1990) 827-832
24. Rumberger J., Brundage B., and Rader D. Kondos G. Electron beam computed tomographic coronary calcium scanning: A review and guidelines for use in asymptomatic persons [published correction appears in Mayo Clin Proc. 1999;74:538]. Mayo Clin Proc 74 (1999) 243-252
25. Kottke B., Moll P., Michels V., and Weidman W. Levels of lipids, lipoproteins, and apolipoproteins in a defined population. Mayo Clin Proc 66 (1991) 1198-1208
26. Maher J., Raz J., Bielak L., et al. Potential of quantity of coronary artery calcification to identify new risk factors for asymptomatic atherosclerosis. Am J Epidemiol 144 (1996) 943-953
27. Peyser P., Bielak L., Chu J., et al. Heritability of coronary artery calcium quantity measured by electron beam computed tomography in asymptomatic adults. Circulation 106 (2002) 304-308
28. Barrett-Connor E. Bush TL. Estrogen and coronary heart disease in women. JAMA 265 (1991) 1861-1867
29. Bracamonte M., Rud K., Owen W., and Miller V. Ovariectomy increases mitogens and plateletinduced proliferation of arterial smooth muscle. Am J Physiol Heart Circ Physiol 283 (2002) H853-H860
30. Jayachandran M., Mukherjee R., Steinkamp T., et al. Differential effects of 17beta-estradiol, conjugated equine estrogen, and raloxifene on mRNA expression, aggregation and secretion in platelets. Am J Physiol Heart Circ Physiol 288 (2005) H2355-H2362
31. Harman S., Brinton E., Cedars M., et al. KEEPS: The Kronos Early Estrogen Prevention Study. Climacteric 8 (2005) 3-12
32. Kanda N. Watanabe S. 17beta-estradiol inhibits the production of RANTES in human keratinocytes. J Invest Dermatol 120 (2003) 420-427
33. Hecht H., Budoff M., Berman D., et al. Coronary artery calcium scanning: Clinical paradigms for cardiac risk assessment and treatment. Am Heart J 151 (2006) 1139-1146
34. Giachelli C. Vascular calcification mechanisms. J Am Soc Nephrol 15 (2004) 2959-2964
35. Shioi A., Nishizawa Y., Jono S., et al. Betaglycerophosphate accelerates calcification in cultured bovine vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 15 (1995) 2003-2009
36. Tintut Y., Parhami F., Boström K., et al. cAMP stimulates osteoblast-like differentiation of calcifying vascular cells. Potential signaling pathway for vascular calcification. J Biol Chem 273 (1998) 7547-7553